IL6 and fibromyalgia: For example, tofacitinib significantly reduces the expression of MMP-3 in chondrocytes and diminishes interleukin-6 (IL-6)-induced inflammatory responses by inhibiting the JAK-STAT pathway.[20] This provides a reference for the treatment of fibromyalgia.